olverembatinib
ascentage pharma
['leusm', 'olverembatinib']
congress #eha2023 | weiyang liu discusses the efficacy and safety of olverembatinib in adults with ph/bcr-abl1 +ve r/r all with t315i mut. n=21. 11 patients reached cr. of 11 pts with molecular r/r diseases, mrd- and cmr rates =72.7% &amp; 63.6% respectively #leusm #allsm 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm